Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Google Shows AI Can Predict Lung Cancer from CT Scans

By HospiMedica International staff writers
Posted on 01 Jun 2019
Google LLC (Mountain View, CA, USA) has shared new research demonstrating how artificial intelligence (AI) can predict lung cancer to boost the chances of survival for people at risk across the world.

Since 2017, Google has been exploring how AI can be used to address the challenges in screening people at a high-risk for lung cancer with lower dose CT screening that leads to unclear diagnosis, subsequent unnecessary procedures, and financial costs. More...
Google used advances in 3D volumetric modeling along with datasets from its partners for modeling lung cancer prediction and laying the groundwork for future clinical testing.

Generally, radiologists go through hundreds of 2D images within a single CT scan with cancer being miniscule and hard to spot. Google researchers created a model that can generate the overall lung cancer malignancy prediction (viewed in 3D volume) as well as identify subtle malignant tissue in the lungs (lung nodules). The model can also factor in information from previous scans, which can be useful in predicting lung cancer risk as the growth rate of suspicious lung nodules can be an indicator of malignancy.

The researchers leveraged 45,856 de-identified chest CT screening cases and validated the results with a second dataset and also compared their results against six US board-certified radiologists. They found that when using a single CT scan for diagnosis, their model performed on par or better than the six radiologists and detected 5% more cancer cases while reducing false-positive exams by more than 11% as compared to unassisted radiologists in the study. Google’s approach achieved an AUC (a common metric used in machine learning that provides an aggregate measure for classification performance) of 94.4%.

With only 2-4% of eligible patients in the US being currently screened for lung cancer, Google’s research demonstrates the potential for AI to increase accuracy as well as consistency, which could help accelerate the adoption of lung cancer screening globally. Google now plans to conduct further studies to assess its impact and utility in clinical practice. It is collaborating with Google Cloud Healthcare and Life Sciences team to serve the model through the Cloud Healthcare API and is holding discussions with its partners across the world to continue additional clinical validation research and deployment.

Related Links:
Google


Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
12-Channel ECG
CM1200B
Morcellator
TCM 3000 BL
Xenon Light Source
CLV-S400
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.